Vertex Pharmaceuticals: Solid Growth But Valuation Still Requires Flawless Execution

Summary

Article title discusses Vertex Pharmaceuticals' growth prospects and valuation, suggesting solid business development but noting execution risks. No specific financial data, catalysts, or clinical updates are provided in the article text.